Grifols (GRFS) News Today $7.82 +0.14 (+1.82%) (As of 12/24/2024 01:48 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Stifel Financial Corp Makes New $1.04 Million Investment in Grifols, S.A. (NASDAQ:GRFS)Stifel Financial Corp acquired a new stake in Grifols, S.A. (NASDAQ:GRFS - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 117,461 shares of the biotechnology company's stock, valued at approximately $1,043,000.December 24 at 3:32 AM | marketbeat.comBarclays PLC Increases Position in Grifols, S.A. (NASDAQ:GRFS)Barclays PLC grew its holdings in Grifols, S.A. (NASDAQ:GRFS - Free Report) by 381.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 592,552 shares of the biotechnology company's stock after purcDecember 21, 2024 | marketbeat.comShort Seller Gotham Asks Judge to Toss Grifols Defamation SuitDecember 21, 2024 | bloomberg.comGrifols (NASDAQ:GRFS) Shares Down 2.7% - Should You Sell?Grifols (NASDAQ:GRFS) Trading Down 2.7% - Here's WhyDecember 20, 2024 | marketbeat.comGrifols (NASDAQ:GRFS) Shares Gap Down - Should You Sell?Grifols (NASDAQ:GRFS) Shares Gap Down - Should You Sell?December 18, 2024 | marketbeat.comGrifols (NASDAQ:GRFS) Trading 5.1% Higher - Should You Buy?Grifols (NASDAQ:GRFS) Trading Up 5.1% - Still a Buy?December 17, 2024 | marketbeat.comGrifols, S.A. 2024 Q3 - Results - Earnings Call PresentationDecember 17, 2024 | seekingalpha.comGrifols shares offer ‘compelling buying opportunity,’ says BerenbergDecember 17, 2024 | markets.businessinsider.comGrifols (NASDAQ:GRFS) Shares Gap Up - Here's WhyGrifols (NASDAQ:GRFS) Shares Gap Up - Should You Buy?December 16, 2024 | marketbeat.comGrifols Seeks to Calm Investors With €1.3 Billion Debt PlacementDecember 11, 2024 | bloomberg.comFlat Footed Calls for Prompt Governance Overhaul at GrifolsDecember 10, 2024 | businesswire.comGrifols, S.A. (NASDAQ:GRFS) Shares Sold by Point72 Asset Management L.P.Point72 Asset Management L.P. lessened its holdings in Grifols, S.A. (NASDAQ:GRFS - Free Report) by 22.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 465,768 shares of the biotechnology company's stock afDecember 9, 2024 | marketbeat.comSEC Drops Probe Into Gotham Over Report on Grifols’ AccountsDecember 5, 2024 | bloomberg.comVerition Fund Management LLC Makes New $2.64 Million Investment in Grifols, S.A. (NASDAQ:GRFS)Verition Fund Management LLC acquired a new position in shares of Grifols, S.A. (NASDAQ:GRFS - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 296,836 shares of the biotechnology company's sDecember 5, 2024 | marketbeat.comMelqart Asset Management UK Ltd Buys New Shares in Grifols, S.A. (NASDAQ:GRFS)Melqart Asset Management UK Ltd purchased a new position in shares of Grifols, S.A. (NASDAQ:GRFS - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 183,351 shares of the biotechnology company's stock, valued at approximately $1,628,0December 4, 2024 | marketbeat.comStatement From Araoz y Rueda on Behalf of Certain Institutional Investors in GrifolsDecember 4, 2024 | businesswire.comMason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas DagaDecember 4, 2024 | businesswire.comGrifols: More Attractive Than In A Very Long TimeNovember 29, 2024 | seekingalpha.comGrifols busca refinanciar deuda y línea de crédito, según su CEONovember 29, 2024 | bloomberg.comCanadian Fund Drops Bid For Spanish Pharma Firm GrifolsNovember 28, 2024 | barrons.comDrugmaker Grifols’s ‘Problems Are Far From Over,’ Says OddoNovember 28, 2024 | bloomberg.comGrifols CEO Says Company in Talks to Refinance Debt, Credit LineNovember 28, 2024 | bloomberg.comGrifols Board Announces Termination Of Discussions With Brookfield - Quick FactsNovember 28, 2024 | markets.businessinsider.comBrookfield drops US$6.8-billion offer to buy drugmaker GrifolsNovember 28, 2024 | financialpost.comGrifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover BidNovember 28, 2024 | marketwatch.comGrifols shares sink after Brookfield walks away from €6.45bn offerNovember 28, 2024 | ft.comBillionaire Grifols Family’s Woes in Focus After Brookfield ExitNovember 28, 2024 | msn.comGrifols Family Says It Won’t Back Another Take-Private DealNovember 27, 2024 | bloomberg.comGrifols shares tumble after report on Brookfield abandoning takeover planNovember 27, 2024 | reuters.comKey deals this week: Amcor, ONEOK, Grifols, N-able and moreNovember 23, 2024 | msn.comGrifols Board Issues Unfavorable Opinion on Brookfield OfferNovember 20, 2024 | yahoo.comGrifols Signals It Would Reject $6.8 Billion Brookfield BidNovember 20, 2024 | bloomberg.comBrookfield considers US$6.9 billion bid for Grifols; shares dipNovember 20, 2024 | financialpost.comGrifols doses first patient in Phase 1 trial of GIGA-2339November 20, 2024 | markets.businessinsider.comGrifols says potential Brookfield offer ‘significantly undervalues’ sharesNovember 20, 2024 | markets.businessinsider.comGrifols: Brookfields potential $6.8 bln offer undervalues the firmNovember 19, 2024 | reuters.comSpanish court opens investigation into Gotham City's attack on GrifolsNovember 19, 2024 | reuters.comMason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of DirectorsNovember 19, 2024 | businesswire.comGrifols (NASDAQ:GRFS) Shares Gap Down - Here's What HappenedGrifols (NASDAQ:GRFS) Shares Gap Down - What's Next?November 18, 2024 | marketbeat.comBrookfield mulls $7.4 bln bid for Spain's Grifols, El Confidencial saysNovember 18, 2024 | reuters.comGrifols spikes as banks reportedly finalize offers for buyout debt dealNovember 14, 2024 | msn.comBanks to Pitch Roughly €11 Billion Buyout Debt Deal for GrifolsNovember 14, 2024 | bloomberg.comGrifols price target raised to EUR 10 from EUR 9 at Deutsche BankNovember 12, 2024 | markets.businessinsider.comGrifols holder Mason Capital opposes potential transaction, tells boardNovember 9, 2024 | markets.businessinsider.comGrifols holder Mason Capital against potential Brookfield dealNovember 9, 2024 | msn.comMason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of DirectorsNovember 8, 2024 | businesswire.comGrifols SA Reports Strong Third Quarter GrowthNovember 8, 2024 | markets.businessinsider.comGrifols (NASDAQ:GRFS) Stock, Option ChainNovember 6, 2024 | benzinga.comBrookfield still pursuing Grifols deal, Bloomberg reportsNovember 6, 2024 | markets.businessinsider.comBrookfield awaiting information for potential Grifols bid, Bloomberg saysNovember 6, 2024 | markets.businessinsider.com Get Grifols News Delivered to You Automatically Sign up to receive the latest news and ratings for GRFS and its competitors with MarketBeat's FREE daily newsletter. Email Address $19 for a FULL YEAR of stock picks?! (Ad)We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $19. But why? Because there is a very small window of time... as little as 25 days from now... That will change the market forever. Click here to get in now>>> GRFS Media Mentions By Week GRFS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRFS News Sentiment▼0.780.68▲Average Medical News Sentiment GRFS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRFS Articles This Week▼44▲GRFS Articles Average Week Get Grifols News Delivered to You Automatically Sign up to receive the latest news and ratings for GRFS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BGNE News UTHR News VTRS News RPRX News SMMT News GMAB News RDY News BMRN News INSM News CTLT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRFS) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grifols, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grifols With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
